Published in Circ Res on July 31, 2008
Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med (2009) 3.75
cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev (2010) 3.27
S-nitrosylation in cardiovascular signaling. Circ Res (2010) 3.02
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. Pharmacol Ther (2009) 1.66
The NO cascade, eNOS location, and microvascular permeability. Cardiovasc Res (2010) 1.43
Pressure-overload magnitude-dependence of the anti-hypertrophic efficacy of PDE5A inhibition. J Mol Cell Cardiol (2008) 1.34
Endothelial dysfunction: a strategic target in the treatment of hypertension? Pflugers Arch (2010) 1.14
A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase. Proc Natl Acad Sci U S A (2009) 1.14
The hemocompatibility of a nitric oxide generating polymer that catalyzes S-nitrosothiol decomposition in an extracorporeal circulation model. Biomaterials (2011) 1.01
Dynamic ligand exchange in soluble guanylyl cyclase (sGC): implications for sGC regulation and desensitization. J Biol Chem (2011) 1.01
Nitroglycerin fails to lower blood pressure in redox-dead Cys42Ser PKG1α knock-in mouse. Circulation (2012) 0.99
Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologies. Antioxid Redox Signal (2011) 0.97
Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction. Int J Mol Sci (2015) 0.96
Activation and inhibition of soluble guanylyl cyclase by S-nitrosocysteine: involvement of amino acid transport system L. Free Radic Biol Med (2009) 0.96
Proteomic and mass spectroscopic quantitation of protein S-nitrosation differentiates NO-donors. ACS Chem Biol (2010) 0.94
Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model. Am J Physiol Heart Circ Physiol (2012) 0.89
Nitric oxide, S-nitrosation, and endothelial permeability. IUBMB Life (2013) 0.87
The nitric oxide pathway and possible therapeutic options in pre-eclampsia. Br J Clin Pharmacol (2014) 0.86
Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress. Antioxid Redox Signal (2015) 0.86
cGMP becomes a drug target. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.85
Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and s-nitrosylation in mouse aorta. J Cardiovasc Pharmacol (2011) 0.85
Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: up-regulation of L-arginine transporters. Biochem J (2013) 0.84
Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS. Br J Pharmacol (2015) 0.83
Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p. J Cell Sci (2012) 0.82
Nitroglycerin-mediated S-nitrosylation of proteins: a field comes full cycle. Circ Res (2008) 0.81
S-nitrosation of proteins: An emergent regulatory mechanism in microvascular permeability and vascular function. Tissue Barriers (2013) 0.80
Reduction of cardiomyocyte S-nitrosylation by S-nitrosoglutathione reductase protects against sepsis-induced myocardial depression. Am J Physiol Heart Circ Physiol (2013) 0.79
Site-specific antioxidative therapy for prevention of atherosclerosis and cardiovascular disease. Oxid Med Cell Longev (2013) 0.79
Cytokine-induced S-nitrosylation of soluble guanylyl cyclase and expression of phosphodiesterase 1A contribute to dysfunction of longitudinal smooth muscle relaxation. J Pharmacol Exp Ther (2014) 0.79
Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow. Front Physiol (2014) 0.78
S-Nitrosoglutathione improves haemodynamics in early-onset pre-eclampsia. Br J Clin Pharmacol (2014) 0.77
Hypothalamic S-nitrosylation contributes to the counter-regulatory response impairment following recurrent hypoglycemia. PLoS One (2013) 0.77
New insights into the role of soluble guanylate cyclase in blood pressure regulation. Curr Opin Nephrol Hypertens (2014) 0.77
Thiol-Based Redox Modulation of Soluble Guanylyl Cyclase, the Nitric Oxide Receptor. Antioxid Redox Signal (2016) 0.77
Tolerance to nitroglycerin through proteasomal down-regulation of aldehyde dehydrogenase-2 in a genetic mouse model of ascorbate deficiency. Br J Pharmacol (2013) 0.77
Biochemical methods for monitoring protein thiol redox states in biological systems. Redox Biol (2014) 0.76
Transnitrosylation: A Factor in Nitric Oxide-Mediated Penile Erection. J Sex Med (2016) 0.76
Identification of novel S-nitrosation sites in soluble guanylyl cyclase, the nitric oxide receptor. J Proteomics (2016) 0.75
The vascular endothelium masks the persistent inhibition of rat thoracic arterial tone induced by S-nitrosoglutathione. Cardiovasc J Afr (2011) 0.75
GSNOR Deficiency Enhances In Situ Skeletal Muscle Strength, Fatigue Resistance, and RyR1 S-Nitrosylation Without Impacting Mitochondrial Content and Activity. Antioxid Redox Signal (2016) 0.75
Glutathione and thioredoxin type 1 cooperatively denitrosate HepG2 cells-derived cytosolic S-nitrosoproteins. Org Biomol Chem (2013) 0.75
Decrease of guanylyl cyclase β1 subunit and nitric oxide (NO)-induced relaxation in mouse rectum with colitis and its reproduction on long-term NO treatment. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.75
Guanylyl Cyclase Sensitivity to Nitric Oxide is Protected by a Thiol Oxidation-Driven Interaction with Thioredoxin1. J Biol Chem (2017) 0.75
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol (2001) 9.82
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther (1981) 6.71
The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE (2001) 6.09
Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res (1977) 3.70
Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem (2003) 3.23
Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest (1995) 2.94
Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci U S A (2002) 2.65
Explaining the phenomenon of nitrate tolerance. Circ Res (2005) 2.36
The biochemistry and physiology of S-nitrosothiols. Annu Rev Pharmacol Toxicol (2002) 2.23
Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest (2004) 2.22
Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation (2001) 2.21
Nitrate therapy for stable angina pectoris. N Engl J Med (1998) 1.80
Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci U S A (2007) 1.78
Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. Am J Physiol Gastrointest Liver Physiol (2006) 1.62
Sulfhydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Ther (1973) 1.57
In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest (1994) 1.53
Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. Eur J Pharmacol (1983) 1.43
Detection and proteomic identification of S-nitrosylated proteins in endothelial cells. Arch Biochem Biophys (2004) 1.36
Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds. FEBS Lett (1980) 1.36
Biochemical mechanism of nitroglycerin action and tolerance: is this old mystery solved? Annu Rev Pharmacol Toxicol (2004) 1.30
Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site? Biochemistry (2004) 1.28
Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta. J Cardiovasc Pharmacol (1987) 1.27
Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation (2001) 1.24
Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels. Circ Res (1994) 1.12
Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. Am J Physiol Heart Circ Physiol (2006) 1.10
Requirement of transmembrane transport for S-nitrosocysteine-dependent modification of intracellular thiols. J Biol Chem (2006) 1.03
Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo. Proc Natl Acad Sci U S A (2004) 1.02
Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites. Clin Pharmacokinet (2003) 1.02
Effects of nitroglycerin on erythrocyte rheology and oxygen unloading: novel role of S-nitrosohemoglobin in relieving myocardial ischemia. Circulation (2006) 0.91
Prevention and reversal of tolerance to nitroglycerine with N-acetylcysteine. J Cardiovasc Pharmacol (1985) 0.90
Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure. J Pharmacol Exp Ther (1991) 0.90
S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries. J Pharmacol Exp Ther (2003) 0.89
Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch. Microvasc Res (2000) 0.87
The chemical dynamics of NO and reactive nitrogen oxides: a practical guide. Curr Mol Med (2004) 0.87
Nitroglycerin tolerance at the platelet level in patients with angina pectoris. Am J Cardiol (1997) 0.83
Effects of chronic in vivo administration of nitroglycerine on ACh-induced endothelium-dependent relaxation in rabbit cerebral arteries. Br J Pharmacol (2007) 0.83
Vasodilator actions of the endothelium-derived relaxing factor L-S-nitrosocysteine in anaesthetized rats are markedly diminished by peroxynitrite. Clin Exp Pharmacol Physiol (2005) 0.80
Interactions of nitroglycerin and sulfhydryl-donating compounds in coronary microvessels. Am J Physiol (1994) 0.80
In vitro vasorelaxant and in vivo cardiovascular effects of S-nitrosothiols: comparison to and cross tolerance with standard nitrovasodilators. Methods Find Exp Clin Pharmacol (1994) 0.78
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab (2008) 2.60
NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism. EMBO J (2007) 2.08
Functional significance of differential eNOS translocation. Am J Physiol Heart Circ Physiol (2006) 1.94
Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction. Am J Physiol Heart Circ Physiol (2005) 1.94
Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci U S A (2007) 1.78
VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol (2002) 1.49
Glucose, insulin, and leptin signaling pathways modulate nitric oxide synthesis in glucose-inhibited neurons in the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol (2006) 1.41
PAS-mediated dimerization of soluble guanylyl cyclase revealed by signal transduction histidine kinase domain crystal structure. J Biol Chem (2007) 1.37
Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo. J Physiol (2006) 1.36
Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase. J Biol Chem (2010) 1.34
AMP-activated protein kinase and nitric oxide regulate the glucose sensitivity of ventromedial hypothalamic glucose-inhibited neurons. Am J Physiol Cell Physiol (2009) 1.32
Role for mitochondrial reactive oxygen species in brain lipid sensing: redox regulation of food intake. Diabetes (2007) 1.29
Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site? Biochemistry (2004) 1.28
Carotid artery stenting: is there a need to revise ultrasound velocity criteria? J Vasc Surg (2004) 1.27
Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells. J Biol Chem (2009) 1.27
Acupuncture reduces experimental renovascular hypertension through mechanisms involving nitric oxide synthases. Microcirculation (2006) 1.26
Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation. Am J Physiol Heart Circ Physiol (2004) 1.20
Nitric oxide-dependent allosteric inhibitory role of a second nucleotide binding site in soluble guanylyl cyclase. J Biol Chem (2005) 1.15
Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability. Proc Natl Acad Sci U S A (2009) 1.14
Fasting enhances the response of arcuate neuropeptide Y-glucose-inhibited neurons to decreased extracellular glucose. Am J Physiol Cell Physiol (2009) 1.12
Pixel distribution analysis of B-mode ultrasound scan images predicts histologic features of atherosclerotic carotid plaques. J Vasc Surg (2002) 1.10
Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. Am J Physiol Heart Circ Physiol (2006) 1.10
Insulin internalizes GLUT2 in the enterocytes of healthy but not insulin-resistant mice. Diabetes (2007) 1.08
Crystal structure of the signaling helix coiled-coil domain of the beta1 subunit of the soluble guanylyl cyclase. BMC Struct Biol (2010) 1.07
p42/44MAPK regulates baseline permeability and cGMP-induced hyperpermeability in endothelial cells. Microvasc Res (2002) 1.03
ACh-induced endothelial NO synthase translocation, NO release and vasodilatation in the hamster microcirculation in vivo. J Physiol (2002) 1.01
Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation. Diabetes (2009) 1.00
Mislocalized opsin and cAMP signaling: a mechanism for sprouting by rod cells in retinal degeneration. Invest Ophthalmol Vis Sci (2012) 0.99
Food intake adaptation to dietary fat involves PSA-dependent rewiring of the arcuate melanocortin system in mice. J Neurosci (2012) 0.99
Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules. Am J Physiol Heart Circ Physiol (2008) 0.97
Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologies. Antioxid Redox Signal (2011) 0.97
S-Nitrosation of β-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability. Circ Res (2012) 0.95
Importance of mitochondrial dynamin-related protein 1 in hypothalamic glucose sensitivity in rats. Antioxid Redox Signal (2012) 0.95
Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability. J Biol Chem (2011) 0.94
Hypothalamic nitric oxide in hypoglycemia detection and counterregulation: a two-edged sword. Antioxid Redox Signal (2010) 0.92
Protein kinase G phosphorylates soluble guanylyl cyclase on serine 64 and inhibits its activity. Arterioscler Thromb Vasc Biol (2008) 0.92
Brain glucose sensing: a subtle mechanism. Curr Opin Clin Nutr Metab Care (2006) 0.91
Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema. Ophthalmology (2013) 0.90
The nitric oxide-cGMP signaling pathway differentially regulates presynaptic structural plasticity in cone and rod cells. J Neurosci (2005) 0.90
Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model. Am J Physiol Heart Circ Physiol (2012) 0.89
Extracellular cAMP inhibits D1 dopamine receptor expression in CAD catecholaminergic cells via A2a adenosine receptors. J Neurochem (2007) 0.89
Characterization of a novel type of endogenous activator of soluble guanylyl cyclase. J Biol Chem (2004) 0.87
Aspartate 102 in the heme domain of soluble guanylyl cyclase has a key role in NO activation. Biochemistry (2011) 0.87
Identification of residues in the heme domain of soluble guanylyl cyclase that are important for basal and stimulated catalytic activity. PLoS One (2011) 0.87
The double-edge sword of TNF-alpha in ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2008) 0.86
Coordinated endothelial nitric oxide synthase activation by translocation and phosphorylation determines flow-induced nitric oxide production in resistance vessels. J Vasc Res (2013) 0.86
Altered proliferative responses of dermal fibroblasts to TGF-beta1 may contribute to chronic venous stasis ulcer. J Vasc Surg (2003) 0.86
Functional proteomics approaches for the identification of transnitrosylase and denitrosylase targets. Methods (2013) 0.85
Endovascular stent graft repair for thoracic aortic aneurysms: the history and the present in Japan. Ann Vasc Dis (2013) 0.85
Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma. Arch Ophthalmol (2012) 0.85
Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: up-regulation of L-arginine transporters. Biochem J (2013) 0.84
Inhibition of nitric oxide-stimulated vasorelaxation by carbon monoxide-releasing molecules. Arterioscler Thromb Vasc Biol (2011) 0.83
Protein disulfide-isomerase interacts with soluble guanylyl cyclase via a redox-based mechanism and modulates its activity. Biochem J (2013) 0.83
Nitric oxide can acutely modulate its biosynthesis through a negative feedback mechanism on L-arginine transport in cardiac myocytes. Am J Physiol Cell Physiol (2010) 0.82
Noninvasive identification of the unstable carotid plaque. Ann Vasc Surg (2006) 0.81
How intensive should radiotherapy for head and neck cancer with synchronous distant metastases be? Review of cases. J Oral Maxillofac Surg (2011) 0.81
Inhibition of topoisomerase II in 32D.3(G) cells by hydroquinone is associated with cell death. J Appl Toxicol (2004) 0.80
Conservative therapy for surgically untreatable extensive arteriovenous malformation from the lower extremity to the pelvis with secondary consumptive coagulopathy. Ann Vasc Dis (2011) 0.80
Long-term results of second-stage thoracic endovascular aortic repair following total aortic arch replacement. Gen Thorac Cardiovasc Surg (2010) 0.80
Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo. Microcirculation (2010) 0.79
Trauma-hemorrhagic shock induces a CD36-dependent RBC endothelial-adhesive phenotype. Crit Care Med (2014) 0.79
Deregulation of hepatic insulin sensitivity induced by central lipid infusion in rats is mediated by nitric oxide. PLoS One (2009) 0.79
Membrane potential dye imaging of ventromedial hypothalamus neurons from adult mice to study glucose sensing. J Vis Exp (2013) 0.77
Hypothalamic S-nitrosylation contributes to the counter-regulatory response impairment following recurrent hypoglycemia. PLoS One (2013) 0.77
Surgical repair for aortic dissection accompanying a right-sided aortic arch. J Cardiothorac Surg (2010) 0.76
Mitogen-activated protein kinases regulate platelet-activating factor-induced hyperpermeability. Microcirculation (2005) 0.76
Using the kinetic Zollner illusion to quantify the interaction between form and motion information in depth. Vision Res (2013) 0.76
Apicoaortic valved conduit bypass for progressing aortic graft stenosis due to malformation of repeated thoracic endovascular aortic repairs. Ann Thorac Surg (2012) 0.75
[Brain glucose sensing]. Bull Acad Natl Med (2008) 0.75
Creation of arteriovenous fistulas upregulates venous eNOS. Vasc Endovascular Surg (2007) 0.75
A potential risk of myocardial ischemia during thoracoabdominal aortic repair after coronary artery bypass grafting using the right gastroepiploic artery. Ann Thorac Cardiovasc Surg (2012) 0.75
A duplex vibriocidal assay to simultaneously measure bactericidal antibody titers against Vibrio cholerae O1 Inaba and Ogawa serotypes. J Microbiol Methods (2009) 0.75
De novo head and neck carcinoma in transplant recipients: preliminary results of management. J Oral Maxillofac Surg (2006) 0.75
Right ventricular dysfunction and the incidence of implantable cardioverter-defibrillator therapies. Pacing Clin Electrophysiol (2009) 0.75